Phase II evaluation of recombinant alpha-2a-interferon and continuous infusion fluorouracil in previously untreated metastatic colorectal adenocarcinoma

MLA

Pazdur, Richard, et al. “Phase II Evaluation of Recombinant Alpha-2a-Interferon and Continuous Infusion Fluorouracil in Previously Untreated Metastatic Colorectal Adenocarcinoma.” Cancer, vol. 71, no. 4, Feb. 1993, p. 1214. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.13639569&authtype=sso&custid=ns315887.

APA

Pazdur, R., Ajani, J. A., Patt, Y. Z., Gomez, J., Bready, B., & Levin, B. (1993, February 15). Phase II evaluation of recombinant alpha-2a-interferon and continuous infusion fluorouracil in previously untreated metastatic colorectal adenocarcinoma. Cancer, 71(4), 1214.

Chicago

Pazdur, Richard, Jaffer A. Ajani, Yehuda Z. Patt, Jesus Gomez, Beth Bready, and Bernard Levin. 1993. “Phase II Evaluation of Recombinant Alpha-2a-Interferon and Continuous Infusion Fluorouracil in Previously Untreated Metastatic Colorectal Adenocarcinoma.” Cancer, February 15. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.13639569&authtype=sso&custid=ns315887.